Application of galangin or salt thereof to preparation of medicines or health-care products capable of preventing and treating lung fibrosis

A technology of pulmonary fibrosis and galangin, applied in the field of medicine, can solve problems such as increased risk of respiratory failure, decreased immunity, liver and kidney damage, etc., and achieves significant clinical and social significance, good curative effect, and low toxicity.
CN110179786AInactive Publication Date: 2019-08-30SICHUAN UNIV
1 Cites 3 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
SICHUAN UNIV
Publication Date
2019-08-30
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to an application of galangin or salt thereof to preparation of medicines or health-care products capable of preventing and treating lung fibrosis, and belongs to the field of medicines. In order to solve the problems that existing medicines capable of treating lung fibrosis are bad in treatment effects and the compliance of a patient is poor, the invention provides the application of galangin or salt thereof to preparation of medicines or health-care products capable of preventing and treating lung fibrosis. In vivo and in vitro experiment proves that the galangin can exert precise treatment effects of the lung fibrosis, and besides, is small in toxicity to human normal liver cells and good in safety. Through the application of the galangin and the salt thereof disclosed by the invention, providing medicines or health-care products which are good in treatment effects, low in toxicity and low in price for patients suffering from lung fibrosis is facilitated, and the application has remarkable clinical and social significance.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the use of galangin or a salt thereof in the preparation of medicines or health products for preventing and treating pulmonary fibrosis, and belongs to the field of medicine. Background technique

[0002] Pulmonary fibrosis (lung fibrosis) is a chronic, progressive lung injury or lung disease to the end of the results. Its pathological features are massive proliferation of fibroblasts, accumulation of extracellular matrix in lung tissue accompanied by inflammatory damage, destruction of alveolar structure, and abnormal repair of tissue damage resulting in scar formation, which hinders the exchange of gas between the lungs and the outside world, eventually leading to respiratory failure. failure and death. The clinical symptoms of pulmonary fibrosis mainly include dyspnea, hypoxemia, and dry cough. With the deterioration of human living environment, pollution and other factors, the incidence of pulmonary fibrosis increases wit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More